Pfizer EBIT 2010-2024 | PFE

Pfizer EBIT for the quarter ending December 31, 2024 was $2.347B, a 154.73% decline year-over-year.

  • Pfizer 2024 EBIT was 12.411B, a 870.37% increase from 2023.
  • Pfizer 2023 EBIT was 1.279B, a 96.43% decline from 2022.
  • Pfizer 2022 EBIT was 35.789B, a 84.17% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Pfizer EBIT 2010-2024 | PFE

  • Pfizer 2024 EBIT was 12.411B, a 870.37% increase from 2023.
  • Pfizer 2023 EBIT was 1.279B, a 96.43% decline from 2022.
  • Pfizer 2022 EBIT was 35.789B, a 84.17% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B